<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The sequential accumulation of genetic alterations has been classically considered responsible for the origin and subsequent progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, although recent cumulative data provide strong evidence of the significance of epigenetic changes in the development of this multi-step <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Among the epigenetic alterations, miRNAs deregulation has emerged as an exciting and promising field in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research </plain></SENT>
<SENT sid="2" pm="."><plain>In a recent issue of the Journal of Pathology, Wang and colleagues identify miR-149 as being silenced by methylation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The authors also identified Sp1 as a target of miR-149 </plain></SENT>
<SENT sid="4" pm="."><plain>These intriguing observations have important biological prognostic and therapeutic implications </plain></SENT>
</text></document>